Stock BKIT BIOHEMP INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company BioHemp International, Inc.

Equities

BKIT

US09076B1052

Pharmaceuticals

Business Summary

BioHemp International, Inc., formerly Blake Insomnia Therapeutics, Inc., is a development-stage pharmaceutical company. The Company operates as a provider of insomnia remedy. The Company is focused on developing its business plan for an insomnia medication known as Zleepax. Zleepax is a sleep aid with beta-blockers as an active agent. As of August 31, 2016, the Company had no revenues.

Number of employees: 1

Managers

Managers TitleAgeSince
Daniel Blum CEO
 Chief Executive Officer 35 14/05/19

Members of the board

Members of the board TitleAgeSince
Daniel Blum CEO
 Chief Executive Officer 35 14/05/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,487,063 14,517 ( 0.5837 %) 0 0.5837 %

Company contact information

Biohemp International, Inc.

244 5th Avenue Suite A-154

10001, New York

+646-453-4912

address BioHemp International, Inc.(BKIT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BKIT Stock
  4. Company BioHemp International, Inc.